Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
06/1998
06/11/1998CA2273203A1 Antisense inhibition of human adhesion molecules
06/11/1998CA2273202A1 Junctional adhesion molecule (jam), a transmembrane protein of tight junctions
06/11/1998CA2273198A1 Human g-protein receptor hcegh45, a pacap-like (g-protein pituitary adenylate cyclase activating polypeptide-like) receptor
06/11/1998CA2273192A1 Inactivation of hiv co-receptors as therapy for hiv infection
06/11/1998CA2273184A1 Alarm related peptides and nucleic acids and diagnosis using them
06/11/1998CA2272994A1 Ve-cadherin promoter and its uses
06/11/1998CA2272851A1 Syndecan enhancer element and its use for targeting gene expression
06/11/1998CA2224334A1 Self-enhancing, pharmacologically controllable expression systems
06/11/1998CA2224131A1 Novel human 11 cb splice variant
06/10/1998EP0846772A1 Multifunctional ligand system for cell-specific transfer of nucleic acid
06/10/1998EP0846767A2 FtsL - A membrane bound protein from Streptococcus pneumoniae
06/10/1998EP0846764A2 Glial cell line-derived neurotrophic factor alpha receptor family
06/10/1998EP0846763A2 A protein phosphatase 1 binding protein, R5
06/10/1998EP0846761A1 A novel transcription factor expressed in cycling cells, nucleic acid molecules encoding said transcription factor and its promoter region and uses thereof
06/10/1998EP0846183A2 High efficiency retroviral packaging system
06/10/1998EP0846181A1 cDNA CORRESPONDING TO THE ANTIGENOME OF NONSEGMENTED NEGATIVE STRAND RNA VIRUSES, AND PROCESS FOR THE PRODUCTION OF SUCH VIRUSES ENCODING ADDITIONAL ANTIGENICALLY ACTIVE PROTEINS
06/10/1998EP0846173A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
06/10/1998EP0846171A2 Chromosome 1 gene and gene products related to alzheimer's disease
06/10/1998EP0846170A1 Modified protein kinase a-specific oligonucleotides and methods of their use
06/10/1998EP0846165A1 Novel filariid nematode cysteine protease proteins, nucleic acid molecules and uses thereof
06/10/1998EP0846128A2 Antimicrobial cationic peptides and methods of screening for the same
06/10/1998EP0846002A1 Circular rna and uses thereof
06/10/1998EP0846001A1 Control of cd44 gene expression for therapeutic use
06/10/1998EP0845981A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
06/10/1998CN1184431A Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence
06/10/1998CN1184420A Production scale method of forming microparticles
06/09/1998US5763575 Agonist and antagonist peptides of the C140 receptor
06/09/1998US5763571 Amino acid sequences which inhibit binding
06/09/1998US5763416 Stimulating bone repair and regeneration
06/09/1998US5763415 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer
06/09/1998US5763275 Method and apparatus for co-culturing cells
06/09/1998US5763270 Plasmid for delivery of nucleic acids to cells and methods of use
06/09/1998US5763268 Hepatitis delta virus compositions and expression vectors
06/09/1998US5763266 Methods, compositions and devices for maintaining and growing human stem and/or hematopoietics cells
06/09/1998US5763246 DNA encoding arginyl tRNA synthetase from staphylococcus aureus
06/09/1998US5763217 Method of using, process of preparing and composition comprising recombinant herpesvirus vectors
06/09/1998US5763216 Introducing an expression vector comprising a promoter linked with a dna molecule, into a host cell to produce genetic engineered cell, culturing the transfored cell, isolating the reduced folate carrier protein from cultured transformed cell
06/09/1998US5763214 Fibroblast growth factor 11
06/09/1998US5763211 Polynucleotide which encodes receptor polypeptide
06/09/1998US5763190 Detecting the human immunodeficiency virus type i protein
06/09/1998US5763156 Effective in regulating inflammatory platelet and endothelial sitmulatory and coagulopathic responses by modulating the activity of the c5b-9 complex of the human plasma complement system by adding a fluorescent potentiometric dye
06/09/1998US5762926 Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
06/04/1998WO1998023782A2 A new ets-related gene overexpressed in human breast and epithelial cancers
06/04/1998WO1998023765A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
06/04/1998WO1998023755A1 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purposes
06/04/1998WO1998023752A2 Papilloma viruses, agents for detecting the same and for treating diseases caused by such viruses
06/04/1998WO1998023749A1 Fibroblast growth factor-13
06/04/1998WO1998023748A1 Methods for preventing graft rejection in transplantation and for producing a universal gene therapy host cell using lymphocyte activation (lag-3)
06/04/1998WO1998023743A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998WO1998023740A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998WO1998023738A2 Novel prokaryotic polynucleotides, polypeptides and their uses
06/04/1998WO1998023730A1 Compounds and methods for treating cancer
06/04/1998WO1998023299A2 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/04/1998WO1998023294A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998WO1998023260A2 Non-ionic surfactant vesicles as a delivery agent for nucleic acid
06/04/1998WO1998013493A3 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
06/04/1998CA2274143A1 Murine guanine nucleotide exchange factor - (mngef) and human homologues thereof
06/04/1998CA2272900A1 Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation
06/04/1998CA2272637A1 Transfecting composition usable in gene therapy combining a recombinant virus incorporating an exogenous nucleic acid, a non-viral and non-plasmid transfecting agent
06/04/1998CA2272345A1 Bmp-4 promoter and use thereof in screening of therapeutic agents for the prevention and/or treatment of osteoporosis
06/04/1998CA2272239A1 Fibroblast growth factor-13
06/04/1998CA2271689A1 Radiolabeled dna oligonucleotide, method of preparation and therapeutic uses thereof
06/03/1998EP0845537A1 Recombinant retroviruses delivering vector constructs to target cells
06/03/1998EP0845535A2 Leader peptidase (lep) from Streptococcus
06/03/1998EP0845530A2 Interferon gamma inducing factor
06/03/1998EP0845529A2 Human G-protein coupled receptor protein cloned form fetal brain CDNA library
06/03/1998EP0845476A2 Synthetic catalytic oligonucleotides
06/03/1998EP0845045A1 Regulation of cellular functions by ectopic expression of non-endogenous cell signalling receptors
06/03/1998EP0845043A1 Transport proteins and their uses
06/03/1998EP0845041A1 Self-deleting vectors for gene therapy
06/03/1998EP0845039A2 Genes and proteins controlling cholesterol synthesis
06/03/1998EP0845034A1 Nucleic acid molecules encoding peptides having pronociceptive properties
06/03/1998EP0845033A1 Aortic preferentially-expressed gene apeg-1 and uses thereof
06/03/1998EP0845032A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
06/03/1998EP0845005A1 Traf inhibitors
06/03/1998EP0844891A1 Hyper comb-branched polymer conjugates
06/03/1998EP0844888A1 Tissue specific viral vectors
06/03/1998EP0844887A1 Aav transduction of myoblasts
06/03/1998EP0844871A1 A process for preparing microparticles through phase inversion phenomena
06/03/1998CN1183806A Polynucleotide immunogenic agents
06/03/1998CN1183801A IL-6 activity inhibitor
06/02/1998US5760180 Kits and dna(cdna) codes and cloning expression vectors
06/02/1998US5760012 Genetic engineered nucleotide for treating genetic disorders
06/02/1998US5759854 Protein
06/02/1998US5759783 Method of screening for cancer by detecting messenger RNA for a MAGE-XP gene
06/02/1998US5759776 Targets for breast cancer diagnosis and treatment
06/02/1998US5759536 Use of fas ligand to supress T-lymphocyte-mediated immune responses
06/02/1998US5759535 Immunotherapeutic strategies for the treatment of cancer
06/02/1998US5759534 Methods of treating disease using sertoli cells and allografts or xenografts
05/1998
05/29/1998CA2217159A1 Multifunctional ligand system for cell-specific transfer of nucleic acid
05/28/1998WO1998022610A1 Novel polymeric complexes for the transfection of nucleic acids, with residues causing the destabilisation of cell membranes
05/28/1998WO1998022609A1 Chimeric adenoviral vectors
05/28/1998WO1998022608A2 Post-mitotic neurons containing adenovirus vectors that modulate apoptosis and growth
05/28/1998WO1998022607A1 Method for producing recombinant virus
05/28/1998WO1998022606A1 Recombinant bicistron adenovirus for treating pathological conditions linked with dyslipoproteinemia
05/28/1998WO1998022605A1 Improved methods for transducing cells
05/28/1998WO1998022589A2 Survivin, a protein that inhibits cellular apoptosis, and its modulation
05/28/1998WO1998022588A2 An improved method for the production and purification of adenoviral vectors
05/28/1998WO1998022587A2 Pituitary-tumor-transforming-genes, and related products
05/28/1998WO1998022586A2 HUMAN POLYHOMEOTIC 2 (hph2) ACTS AS A TUMOR SUPPRESSOR
1 ... 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 ... 870